Human Papilloma Virus
A recent papillomavirus research study discusses the HPV vaccination and the necessary doses. Currently, the HPV vaccine requires a series of three doses for adolescents 15 years and older and a series of 2 doses for those 15 years and younger. Vaccination for HPV is a rising global initiative. But unfortunately, the three dose requirement is a huge logistical and financial limitation for developing countries who need the vaccine the most.
Recent observations have determined that vaccine induced protection is present even when there are small amounts of detectable antibodies. This raises the question if the HPV vaccine can become a two series vaccine for all age groups. Trials have shown that two and three dose series have comparable titres or levels of immunity. More research needs to be done to confirm this idea. However, I find this very promising and could potentially bring protection to a huge population of those who would otherwise not have access.
Another article describes an interesting approach inline with the same HPV vaccination initiative in a middle school in rural Texas. This rural middle school had very low HPV vaccination rates and became the home to a school-based vaccination program. This program involved physician led HPV education and vaccinations. This program proved to be very successful and HPV vaccination and completion rates were higher than schools in the surrounding area who had not undergone intervention. What a cool and creative way to bring health care to underserved populations!
Kinsey's Blog 